Alpha-tocopherol and astaxanthin decrease macrophage infiltration, apoptosis and vulnerability in atheroma of hyperlipidaemic rabbits

Journal of Molecular and Cellular Cardiology

Volumn 37, Issue 5, 2004, Pages 969-978

  Li, Wei ^a   Hellsten, Anna ^a   Jacobsson, Leif S ^a   Blomqvist, Henrik M ^a   Olsson, Anders G ^a   Yuan, Xi Ming ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Antioxidants; Apoptosis; Atherosclerosis; Cellular lipids; Collagen; Macrophages; WHHL rabbits

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASTAXANTHIN; COLLAGEN; LIPID; MATRIX METALLOPROTEINASE;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; HYPERLIPIDEMIA; LIPID STORAGE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SMOOTH MUSCLE FIBER;

ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; APOPTOSIS; ARTERIOSCLEROSIS; BETA CAROTENE; CELL MOVEMENT; COLLAGEN; HYPERLIPIDEMIAS; LIPID PEROXIDATION; LIPIDS; MACROPHAGES; MATRIX METALLOPROTEINASE 3; RABBITS; XANTHOPHYLLS;

ORYCTOLAGUS CUNICULUS;

EID: 7444266395     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.07.009     Document Type: Article

References (27)

1. F.M. Sacks, J.L. Rouleau, L.A. Moye, M.A. Pfeffer, J.W. Warnica, and J.M. Arnold Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels Am. J. Cardiol. 75 1995 621 623
2. Scandinavian Simvastatin Survival Study Group Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
3. J. Kjekshus, T. Pedersen, and J. Tobert Lipid lowering therapy for patients with or at risk for coronary artery disease Curr. Opin. Cardiol. 11 1996 418 427
4. R.T. Lee, and P. Libby The unstable atheroma Arterioscler. Thromb. Vasc. Biol. 17 1997 1859 1867
5. M.J. Davies Apoptosis in cardiovascular disease Heart 77 1997 498 501
6. E. Falk Stable versus unstable atherosclerosis: clinical aspects Am. Heart J. 138 1999 S421 S425
7. D. Sumi, T. Hayashi, N.K. Thakur, M. Jayachandran, Y. Asai, and H. Kano A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects - the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action Atherosclerosis 155 2001 347 357
8. R.B. Singh, N.K. Singh, S.S. Rastogi, G.S. Wander, M. Aslam, and Z. Onouchi Antioxidant effects of lovastatin and vitamin E on experimental atherosclerosis in rabbits Cardiovasc. Drugs Ther. 11 1997 575 580
9. E.B. Rimm, and M.J. Stampfer Antioxidants for vascular disease Med. Clin. North Am. 84 2000 239 249
10. I. Jialal, and S. Devaraj Antioxidants and atherosclerosis: do not throw out the baby with the bath water Circulation 25 2003 926 928
11. R.M. Salonen, K. Nyyssonen, J. Kaikkonen, E. Porkkala-Sarataho, S. Voutilainen, and T.H. Rissanen Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study Circulation 107 2003 947 953
12. A.G. Olsson, and X.M. Yuan Antioxidants in the prevention of atherosclerosis Curr. Opin. Lipidol. 7 1996 374 380
13. N. Kaul, S. Devaraj, and I. Jialal Alpha-tocopherol and atherosclerosis Exp. Biol. Med. 226 2001 5 12
14. R.T. Lorenz, and G.R. Cysewski Commercial potential for Haematococcus microalgae as a natural source of astaxanthin Trends Biotechnol. 18 2000 160 167
15. J. Terao Antioxidant activity of beta-carotene related carotenoids in solution Lipids 24 1989 659 662
16. M. Kurashige, E. Okimasu, M. Inoue, and K. Utsumi Inhibition of oxidative injury of biological membranes by astaxanthin Physiol. Chem. Phys. Med. NMR 22 1990 27 38
17. L.S. Jacobsson, X.M. Yuan, B. Ziedén, and A.G. Olsson Effects of α-tocopherol and astaxanthin on LDL oxidation and atherosclerosis in WHHL rabbits Atherosclerosis 173 2004 231 237
18. H.K. Hanel, and H. Dam Determination of small amounts of total cholesterol by the Tshugaeff reaction with a note on the determination of lathosterol Acta. Chem. Scand. A. 9 1955 677 682
19. T. Iwamoto, K. Hosoda, R. Hirano, H. Kurata, A. Matsumoto, and W. Miki Inhibition of low-density lipoprotein oxidation by astaxanthin J. Atheroscler. Thromb. 7 2000 216 222
20. J.H. Brasen, K. Koenig, H. Bach, A. Kontush, H. Heinle, and P.K. Witting Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits Atherosclerosis 163 2002 249 259
21. X.M. Yuan, U.T. Brunk, and L. Hazell The morphology and natural history of atherosclerosis R. Dean D. Kelley Atherosclerosis 2000 Oxford University Press London 1 23
22. Z.S. Galis, and J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly Circ. Res. 90 2002 251 262
23. P.N. Seshiah, D.J. Kereiakes, S.S. Vasudevan, N. Lopes, B.Y. Su, and N.A. Flavahan Activated monocytes induce smooth muscle cell death: role of macrophage colony-stimulating factor and cell contact Circulation 105 2002 174 180
24. W. Li, H. Dalen, J.W. Eaton, and X.M. Yuan Apoptotic death of inflammatory cells in human atheroma Arterioscler Thromb. Vasc. Biol. 21 2001 1124 1130
25. W. Li, X.M. Yuan, A.G. Olsson, and U.T. Brunk Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation Arterioscler. Thromb. Vasc. Biol. 18 1998 177 184
26. M.D. Rekhter How to evaluate plaque vulnerability in animal models of atherosclerosis? Cardiovasc. Res. 54 2002 36 41
27. M. Guerin, M.E. Huntley, and M. Olaizola Haematococcus astaxanthin: applications for human health and nutrition Trends Biotechnol 21 2003 210 216